Thrombotic risk factors associated with transurethral prostatectomy

BJU International

Volumn 83, Issue 9, 1999, Pages 984-989

  Bell, C R W ^a,b   Murdock, P J A ^a   Pasi, K J ^a   Morgan, R J ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

Anticoagulation prophylaxis; Hypercoagulable state; Transurethral prostatectomy

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; D DIMER; FIBRINOGEN; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; CLINICAL ARTICLE; HUMAN; HYPERCOAGULABILITY; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROSTATE DISEASE; PROTHROMBIN TIME; RISK ASSESSMENT; RISK FACTOR; TIME; TRANSURETHRAL RESECTION; VEIN THROMBOSIS;

ANTICOAGULANTS; BLOOD COAGULATION FACTORS; BLOOD LOSS, SURGICAL; HEMOSTASIS; HUMANS; MALE; PROSPECTIVE STUDIES; PROSTATECTOMY; RISK FACTORS; THROMBOSIS;

EID: 0032973565     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1999.00075.x     Document Type: Article

References (39)

1. 1 Office of Population and Census Survey. Hospital in-Patient Enquiry. HMSO (series MB4 No27) 1985
2. 2 Doll HA, Black NA, McPherson K, Flood AB, Williams GB, Smith JC. Morbidity, mortality and complications following transurethral resection of the prostate for benign prostatic hypertrophy. J Urol 1992; 147: 1566-73
3. 3 Hedland PO. Postoperative venous thrombosis in benign prostatic disease. A study of 316 patients using the 125 I-Fibrinogen uptake test. Scand J Urol Nephrol 1975; 27: 1-100
4. 4 Van Arsdalen K, Barnes RW, Clarke G, Smith MJV, Koontz WW. Deep vein thrombosis and prostatectomy. Urology 1983; 21: 461-1
5. 5 Melchior J, Valk WI, Foret JD, Mebust WK. Transurethral prostatectomy: computerised analysis of 2223 consecutive cases. J Urol 1974; 112: 634-42
6. 6 Kass EJ, Sonda P, Gershon C, Fischer CP. The use of prophylactic low dose heparin in transurethral prostatectomy. J Urol 1978; 120: 186-7
7. 7 Sleight MW. The effect of prophylactic subcutaneous heparin on blood loss during and after transurethral prostatectomy. Br J Urol 1982; 54: 164-5
8. 8 Wilson RG, Smith D, Paton G, Gollock JM, Bremner DN. Prophylactic subcutaneous heparin does not increase operative blood loss in transurethral resection of the prostate. Br J Urol 1988; 62: 246-8
9. 9 Watson CJE, Deane AM, Doyle PT et al. Identifiable factors in post-prostatectomy haemorrhage: the role of aspirin. Br J Urol 1990; 66: 85-7
10. 10 Donat R, McNeill A, Brame KG. Aiui-platelet and non-steroidal anti-inflammatory drugs in transurethral surgery of the prostate and bleeding complications. Br J Urol 1996; 77: 31, A120
11. 11 Adamson AS, Francis JL, Witherow RON, Snell ME. Procoagulant properties of benign and malignant prostatic tissue. Br J Urol 1994; 74: 204-9
12. 12 Jansen H, Berseus O, Johansson JE, A simple photometric method for determination of blood loss during transurethral surgery. Scand J Urol Nephrol 1978; 12: 1-5
13. 14 Hahn RG. Ethanol monitoring of irrigating fluid absorption. Eur J Anaesth 1996; 13: 102-15
14. 14 Fearnley GR, Balmforth G, Fearnley E. Evidence of a diurnal fibrinolytic rhythm with a simple method of measuring fibrinolysis. Clin Sci 1957; 16: 645-50
15. 15 Hnatowich DJ, Virizi F, Rucsckowski M. Investigations of avidin and biotin for imaging applications. J Nucl Med 1987; 28: 1294-302
16. 16 Dawes J, James K, Micklem LR, Pepper DS, Prowse CV. Monoclonal antibodies directed against human α-thrombin and thrombin-antithrombin III vomplex. Thrombosis Res 1984; 36: 397-409
17. 17 Mannucci PM. Mechanisms, markers and management of coagulation activation. Br Med Bull 1994; 50: 851-70
18. 18 Gallus AS, Hirsh J, Gent M. Relevance of preoperative and postoperative blood tests to postoperative leg-vein thrombosis. Lancet 1973; 2: 806-9
19. 19 Bell CRW, Cox DJA, Murdock PJ, Sullivan ME, Pasi KJ, Morgan RJ. Thrombelastographic evaluation of coagulation in transurethral prostatectomy. Br J Urol 1996; 78: 737-41
20. 20 Bauer KA, Rosenberg RD. The pathophysiology of the prethrombotic state in humans: insight gained from studies using markers of haemostatic system activation. Blood 1987; 70: 343-50
21. 21 Nielsen JD, Gram J, Fabrin K, Holm-Nielsen A, Jespersen J. Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate. Br J Urol 1997; 80: 105-10
22. 22 Ahsan Z, Gartner R, English PJ. Coagulation tests in predicting haemorrhage after prostatic resection. Br J Urol 1993; 72: 201-6
23. 23 Betkurer V, Guinan P, Verma A et al. The effect of transurethral resection on coagulation in carcinoma of prostate. Urology 1979; 13: 142-4
24. 24 de Campos Freire G, de Campos Pachelli L, Cordeiro P, Borrelli M, Menezes de Goes G. Blood loss during and following transurethral resection. The Prostate 1986; 8: 87-92
25. 25 Grant PJ, Tate GM, Davies JA, Williams NS, Prentice CRM. Intra-operative activation of coagulation - a stimulus to thrombosis mediated by vasopressin? Thromb Haemostas 1986; 55: 104-7
26. 26 Mansfield AO. Alteration in fibrinolysis associated with surgery and venous thrombosis. Br J Surg 1972; 59: 754-7
27. 27 D'Angelo A, Kluft C, Verheijen JH, Rijken DC, Mozzi E, Mannucci PM. Fibrinolytic shut-down after surgery: impairment of the balance between tissue-type plasminogen activator and its specific inhibitor. Eur J Clin Invest 1985; 15: 308-12
28. 28 Ingram GIC, Vaughan Jones R. The rise in clotting factor VIII induced in man by adrenaline: effect of α and βblockers. J Physiol 1966; 187: 447-54
29. 29 Tuman KJ, Spiess BD, McCarthy RJ. Effects of progressive blood loss on coagulation as measured by thrombelastography. Anaesth Analg 1987; 66: 856-63
30. 30 Collins JA, Knudson MM. Massive transfusion. In Rossi EC, Simon TL, Moss GS. eds, Transfusion Medicine. Baltimore MD: Williams and Wilkins, 1991: 419-27
31. 31 Ruttmann TG, James MFM, Viljoen JF. Haemodilution induces a hypercoagulable state. Br J Anaesth 1996; 76: 412-4
32. 32 Grathwohl KW, Bruns BJ, LeBrun CJ, Ohno AK, Dillard TA, Cushner HM. Does hemodilution exist? Effects of saline infusion on hematological parameters in euvolemic patients. South Med J 1996; 89: 51-5
33. 33 O'Donnell PD. Effects of intravenous infusion of human prostate tissue substances in dogs. The Prostate 1990; 16: 49-56
34. 34 O'Donnell PD, Finan BF, Fody EP. Acid phosphatase elevation with symptoms following transurethral prostatic resection. J Urol 1984; 131: 684-6
35. 35 Spero J, Lewis J, Hasiba U. Disseminated intravascular coagulation. Findings in 346 patients. Thomb Haemost 1980; 43: 28-33
36. 36 Rader ES. Haematological screening tests in patients with operative prostatic disease. Urology 1978; 11: 243-6
37. 37 Gallimore SC, Hoile RW, Ingram GS, Sherry KM. Report of the National Confidential Enquiry Into Perioperative Deaths. London: 1994/1995 National Confidential Inquiry into Perioperative Deaths 1997
38. 58 Hammadeh MY, Madaan S, Singh M, Philp T. Two-year follow-up of a prospective randomized trial of electrovaporization versus resection of the prostate. Eur Urol 1998; 34: 188-92
39. 39 Kakkar VV, Cohen AT, Edmonson RA et al. Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. Lancet 1993; 341: 243-57